Biochemical Modulators Product Flyers

Antiviral Compounds (4 Page Flyer)

AdipoGen Life Sciences offers a broad range of antiviral compounds that target viral entry, transcription, replication, assembly and/or release of infectious viral particles in different virus types.

Released - August 2024

HDAC & HAT Modulators (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of HDAC and HAT inhibitors, compounds that interfere with the function of histone acetyltransferases (HATs) and histone deacetylases (HDACs), thereby exhibiting antitumor activity against various tumor cells by blocking cell cycle progression and inducing apoptosis.

Released - August 2024

Small Molecule Angiogenesis Inhibitors (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of small-molecule angiogenesis inhibitors that target the most important pathways, such as VEGF, FGF, PDGF, Tie/HIF and MMP that promote blood vessel formation within tumors.

Released - August 2024

Metabolic Research Compounds / Modulators (4 Page Flyer)

AdipoGen Life Sciences offers a broad range of metabolic pathway modulators, targeting glucose homeostasis, energy balance, ER stress, or are useful for studying metabolism-related diseases.

Released - August 2024

GLP-1R, GIPR & GCGR Agonists (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of peptide-based tools for Obesity & Diabetes Research. This includes many glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide (GIPR) and glucagon receptor (GCGR) agonists.

Released - May 2024

AMPK Modulators (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of AMPK activators, which are compounds or substances that stimulate the activity of AMPK. These activators can work through various mechanisms to increase the activity of AMPK, ultimately leading to changes in cellular metabolism and energy balance.

Released - April 2024

PPAR Modulators (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of synthetic PPAR modulators. PPARα agonists (e.g. fibrates) lower triglycerides and reverse insulin resistance and some of the antihypertriglyceridemic mechanisms of PPARβ/δ agonists involve AMPK activation. Thiazolidinediones (TZDs) are PPARγ agonists primarily used for insulin sensitization in the treatment of type 2 diabetes and metabolic syndrome.

Released - April 2024

Manumycin A - Exosome Biogenesis Inhibitor (2 Page Flyer)

AdipoGen Life Sciences offers a broad range of exosome biogenesis modulators (e.g. Manumycin A), standard exosome markers (e.g. CD9, CD63, CD81) and exosomal capturing/sorting biomarkers (Tim-4).

Released - March 2024